Proチャート

Drugs Made In America Acq...

NasdaqGM: DMII · リアルタイム株価 · USD
10.13
+0.00 (0.00%)
終値時点: Aug 12, 2026, 1:20 PM

事業内容

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. logo
United States
IPO日2025年12月3日
業種Shell Companies
セクターFinancial Services
従業員数n/a
CEOMr. Roger Bendelac

連絡先

住所:
420 Lexington Avenue
New York, NY
United States
ウェブサイトn/a

銘柄情報

ティッカーDMII
取引所NasdaqGM
決算期Jan '25 - Dec '25
報告通貨USD
CIKコード0002040475
CUSIP番号n/a
ISIN番号n/a
雇用者番号n/a
SICコードn/a

主な役員

氏名役職
Mr. Roger BendelacChief Executive Officer
Mr. Saleem Elmasri CPACFO & Principal Accounting Officer

最新のSEC提出書類

SEC提出書類はありません。